THIS PRE-ORDER WILL END ON AUGUST 20TH AT 8PM. PLEASE MAKE SURE ALL ORDERS ARE SUBMITTED BY THEN. ORDERS WILL PRINT AND SHIP THE WEEK OF SEPTEMBER 6TH.
In March 2021, Joel (JJ) was diagnosed with acute lymphoblast leukemia with CNS. These products were created as a way to show love and support to JJ and this family. All proceeds will go directly to the Parks family. The Parks older boys are struggling with having to wear masks. Hopefully, these masks and shirts will help them feel they are helping their little brother out.
- 4.2 oz., 52/48 Airlume combed and ring-spun cotton/polyester, 32 singles
- Dual-compacted, 2-ply jersey
- Tailored to fit the contour of the nose and chin
- Strategic shirring on nose and chin for a face-hugging fit
- Fabric ear loops straps made of 1/4" single fold stretchy binding
- Sold in poly-bagged packs of 72 face covers. 1 unit = 72 face covers
*Specs do not include the ear loops
Wash/Care: Machine wash separately on hot. Only non-chlorine bleach. Medium dry heat separately. Medium iron. Do not dry clean.
All face cover sales are final and non-returnable.
Disclaimer: The mask should not be used (1) in any surgical setting or where significant exposure to liquid, bodily or other hazardous fluids, may be expected; (2) in a clinical setting where the infection risk level through inhalation exposure is high; or (3) in the presence of a high intensity heat source or flammable gas. Bella+Canvas, LLC and S&S Activewear make no warranties, either express or implied, that the face cover prevents infection or the transmission of viruses or diseases.
The product has been authorized by FDA under an EUA for use as source control by the general public as well as by HCP in healthcare settings as to help prevent the spread of infection or illness during the COVID-19 pandemic. The product has not been FDA cleared or approved. This product is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of medical devices, including alternative products used as medical devices, during the COVID-19 outbreak, under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1) unless the authorization is terminated or revoked sooner.